# Page 1
To grant administrative approval for procurement of essential medicines under COVID-19 measures by Haffkine Corporation.
The Government of Maharashtra
Department of Medical Education and Drugs
Government Resolution No.Covid-2020/ P.S.No.268/ Administration-2
Mantralaya, Mumbai- 400 032
Date of Birth: November 20, 2020
Reference: 1) Government Decision, Department of Public Health, No. Purchase 2016/ Q.No.82/ Part-III, Industry-4, dated 01.12.2016
(2) Government Resolution, Department of Industry, Energy and Labor, No. 2014/ No.
240/ QS-2, dated 26.07.2017
(3) Government Resolution, Finance Department, No. 2013/ No. 30/13/ Regulations D. 17.04.2015
4) Letter from the Director, Medical Education and Research, Mumbai No.
5911/2020, D.O./ Administrative Sanction and Funds. 01.10.2020
5) Letter from the Director, Medical Education and Research, Mumbai No. 21 per cent.
Fertilizer/ COVID-19/ Authors- 1/731/2020 D. 10.10.2020
6) Letter from Director, Medical Education and Research, Mumbai No. 21 per cent.
Fertilizer/ COVID-19/ Authors- 1/747-A/ 2020D. 14.10.2020
7) Department of Medical Education and Pharmaceuticals, Government Decision No. COVID-2020/ No.268/ Administration-2, Dy. 20.10.2020
8) Director, Medical Education and Research, Mumbai vide letter No. Samvaishivasam/ Authors/ 2171/ 2020D. 19.11.2020
Government's decision:
Purchase of Medicinal and Surgical Materials, Chemicals and Equipment etc., required for Government Medical Colleges and Hospitals and Institutions under the Department of Medical Education and Pharmaceuticals as per Government Decision dated 26.07.2017 of the Public Health Department.
# Page 2
Government Decision No.Covid-2020/ P.No.268/ Administration-2 has made it mandatory to procure from Haffkine Jeeva Pharmaceutical Corporation.
For COVID-19 measures, in the September, 2020 session, Rs. A proposal for a supplementary demand of Rs. 300.00 crore has been approved. Accordingly, as proposed by the Director, Medical Education and Research, Mumbai, the Government vide its decision dated 20.10.2020 had approved the procurement of items worth Rs. 53,73,72, 000/- (Rupees Fifty Three Crore Seventy Three Lakh Seventy Two Thousand only) for non-ICU (Non-Covid-19) hospitals from Haffkine Corporation. However, as per the request made by the Director, Medical Education& Research, Mumbai vide letter dated 19.11.2020, vide administrative approval order dated 20.10.2020, the Emergency Medicine required for Covid has been increased to Rs. Revised administrative approval is being granted to Haffkine Corporation for procurement of items mentioned in Annexure-A for an amount of Rs. 107,47,44, 938/- (Rupees One Hundred and Seven Crores Forty Seven Lakh Forty Four Thousand Nine Hundred and Thirty Eight only) subject to further terms and conditions.
Terms and Conditions: 1) As per the Government decision dated 26.07.2017 of the Public Health Department, it has been made mandatory to purchase the medicinal and surgical materials, chemicals and equipment etc. required by the Government Medical Colleges and Hospitals and Institutions under the Medical Education and Pharmaceuticals Department from the Haffkine Jeeva Drug Manufacturing Corporation. This should be purchased.
(2) The Directorate shall verify the requirement/ demand of the said medicinal and surgical materials, chemicals and equipment etc.
(3) It shall be ensured that the specifications of the said medicinal and surgical materials, chemicals and equipment etc. are comprehensive and comprehensive in such a way that three tenders can be received from three manufacturers/ suppliers who can supply the said items.
4) In this regard, the Government issued a rule book on the procedure for office procurement to be carried out by the Government Department.
# Page 3
Government Decision No.Covid-2020/ P.S. 268/ Administration-2 Decision No. Bhankhas-2014/ Q.No.82/ Part/ Industry-4, Dy. The prescribed procedure as mentioned in 01.12.2016 should be followed.
5) It should be ensured that the items proposed for purchase are not left unused and are used within the stipulated time.
6) It should be ensured that there is no duplication of purchase matters.
7) The Director, Medical Education and Research, Mumbai shall take immediate further necessary action to obtain the said medicine and related matters from Haffkine Pharmaceuticals Corporation.
8) Under no circumstances should be spent more than the limit of available funds.
9) The Director, Medical Education, Mumbai vide his letter dated 2210-3314 vide Supplementary Demands for Grants for containment of COVID-19 has released Rs. 107,47,44, 938/- (Rupees One Hundred and Seven Crores Forty Seven Lakhs Forty Four Thousand Nine Hundred and Thirty Eight only) should be transferred to Haffkine Corporation immediately.
The Director, Medical Education and Research, Mumbai and the Joint Director, Directorate of Medical Education and Research (Procurement Cell), Mumbai shall be solely responsible for fulfilling the conditions mentioned in the above Annexure 1 to 9 and to ensure that the procurement is as per rules and requirements.
The expenditure for the purchase of the above items should be met from the next head of account of the Director, Medical Education and Research, Mumbai.
Demand No-S-1
2210- Medical Services and Public Health
01- Civil Health Service
1- Management and Administration.
Director of Medical Education and Research, Mumbai.
(2210 3314)
21- Supplies and Supplies
4. Government Resolution, Department of Finance, S.R.V. 2013/ Q.No. 30/13/ Regulations D. 17.04.2015 as well as in Part-I, Sub-Division-II of the Financial Powers Rules,
# Page 4
This Government decision is being issued under the authority of the Administrative Department as per Government Decision No. COVID-2020/ PR No. 268/ Administration-2, Roll No. 3, Rule No. 7.
# Page 5
# Page 6